BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17216853)

  • 1. Anti-cancer agents. Unique protocol looks promising for lymphoma.
    TreatmentUpdate; 2003; 15(4):5-7. PubMed ID: 17216853
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of the treatment of HIV-associated lymphoma.
    Kaplan LD
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
    Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
    Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
    J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
    Little RF; Pittaluga S; Grant N; Steinberg SM; Kavlick MF; Mitsuya H; Franchini G; Gutierrez M; Raffeld M; Jaffe ES; Shearer G; Yarchoan R; Wilson WH
    Blood; 2003 Jun; 101(12):4653-9. PubMed ID: 12609827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related lymphoma treated with maintenance thalidomide.
    Larson ML; Enschede SH; Gregory SA
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):231-4; discussion 234-5. PubMed ID: 16166993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
    Zheng W; Zhu J; Xie Y
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor.
    Hernàndez DE; Hernàndez AE
    Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
    Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
    Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide.
    Bower M; Powles T; Stebbing J; Thirlwell C
    J Clin Oncol; 2005 Feb; 23(6):1328-9; author reply 1329-30. PubMed ID: 15718342
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
    Ramos JC; Sparano JA; Chadburn A; Reid EG; Ambinder RF; Siegel ER; Moore PC; Rubinstein PG; Durand CM; Cesarman E; Aboulafia D; Baiocchi R; Ratner L; Kaplan L; Capoferri AA; Lee JY; Mitsuyasu R; Noy A
    Blood; 2020 Sep; 136(11):1284-1297. PubMed ID: 32430507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
    Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
    Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
    Okada S
    Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
    Cheson BD; Feigal EG
    Oncology (Williston Park); 1993 Apr; 7(4):37-8. PubMed ID: 7683481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colony-stimulating factors and HIV-related neoplasms].
    Valencia ME; Moreno V; Soriano V; Polo R; Verdejo J; Laguna F; González Lahoz J
    An Med Interna; 1996 Jul; 13(7):317-21. PubMed ID: 8962975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor melt: primary effusion lymphoma of the heart.
    Kriekard P; Garcia JA; Nardi-Korver L; Krantz MJ
    Am J Med; 2012 Sep; 125(9):e5-6. PubMed ID: 22682793
    [No Abstract]   [Full Text] [Related]  

  • 19. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
    Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
    AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
    Boulanger E; Brière J; Gaulard P; Droz D; Oksenhendler E
    Am J Hematol; 2003 Jan; 72(1):70-1. PubMed ID: 12508272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.